Cargando…

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke

INTRODUCTION: This study aimed to investigate the long-term prognostic effects of different alteplase doses on patients with acute ischemic stroke (AIS). METHODS: In this cohort study, we enrolled 501 patients with AIS treated with intravenous thrombolysis with alteplase, with the primary endpoint e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Mingfeng, Cao, Shugang, Yang, Jinwei, Cao, Xiaoyan, Dong, Zhong, Liu, Wanyin, Fu, Yongzhan, Guan, Qiyue, Wang, Yu, Liu, Hongbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310604/ https://www.ncbi.nlm.nih.gov/pubmed/37166676 http://dx.doi.org/10.1007/s40120-023-00488-3

Ejemplares similares

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Shen, Ziyi, et al.
Publicado: (2023)

Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke
por: Sivanandy, Palanisamy, et al.
Publicado: (2011)

Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022)

Thrombolytic Therapy in the Oldest Old: Successful Alteplase Administration in a 105-Year-Old Female With Ischemic Stroke
por: Bhandari, Sambhawana, et al.
Publicado: (2021)

Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke
por: Chalos, Vicky, et al.
Publicado: (2019)

Low versus standard dose intravenous alteplase in the treatment of acute ischemic stroke in Egyptian patients
por: Salem, Gelan M., et al.
Publicado: (2021)

Impact of Medical Community Model on Intravenous Alteplase Door-to-Needle Times and Prognosis of Patients With Acute Ischemic Stroke
por: Li, Hongfei, et al.
Publicado: (2022)

Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis
por: Huang, Pan, et al.
Publicado: (2023)

Low-dose vs. standard-dose intravenous alteplase for acute ischemic stroke with unknown time of onset
por: Wang, Zekun, et al.
Publicado: (2023)

Retrospective Evaluation of the Results of Low-Dose Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
por: Cetiner, Mustafa, et al.
Publicado: (2023)

Early and intermediate prognosis of intravenous thrombolytic therapy in acute ischemic stroke subtypes according to the causative classification of stroke system
por: Pashapour, Ali, et al.
Publicado: (2013)

A Case of Acute Ischemic Stroke Treated With Alteplase Immediately After Transcatheter Aortic Valve Implantation: Which Procedures or Surgeries are Considered Contraindications to Thrombolytics?
por: Mughnetsyan, Rafik, et al.
Publicado: (2022)

Effects of alteplase in the treatment of acute ischemic stroke
por: Yayan, Josef
Publicado: (2012)

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013)

Predicting prognosis in patients with stroke treated with intravenous alteplase through blood pressure changes: A machine learning‐based approach
por: Fan, Kaiting, et al.
Publicado: (2023)

Mean Platelet Volume, C-Reactive Protein, and Prognosis in Patients with Acute Ischemic Stroke Following Intravenous Thrombolytic Treatment
por: İnanç, Yusuf, et al.
Publicado: (2018)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Retrosternal mass: An interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013)

Predictive Factors for Functional Outcomes After Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
por: Çetiner, Mustafa, et al.
Publicado: (2018)

Intravenous thrombolytic therapy in acute ischemic stroke: The art and science of treatment decision making
por: Sylaja, P. N., et al.
Publicado: (2008)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Impact of Intravenous Alteplase Door-to-Needle Times on 2-Year Mortality in Patients With Acute Ischemic Stroke
por: Bhatt, Nirav R., et al.
Publicado: (2021)

Safety and efficacy of alteplase in the treatment of acute ischemic stroke
por: Micieli, Giuseppe, et al.
Publicado: (2009)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study
por: Kim, Jong S., et al.
Publicado: (2018)

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022)

Association between computed tomography perfusion and the effect of intravenous alteplase prior to endovascular treatment in acute ischemic stroke
por: Hoving, Jan W., et al.
Publicado: (2023)

Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation
por: Ayromlou, Hormoz, et al.
Publicado: (2014)

Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke
por: Mair, Grant, et al.
Publicado: (2017)

Renal Dysfunction and In‐Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy
por: Rao, Zhen‐Zhen, et al.
Publicado: (2019)

Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative
por: Sasanejad, Payam, et al.
Publicado: (2021)

Thrombolytic Dilemma: A Case Report of Early Puerperium Ischemic Stroke Treated With Intravenous Thrombolysis
por: Santos, André, et al.
Publicado: (2023)

Thrombolytic treatment (alteplase; rt-Pa) in acute massive pulmonary embolism and cardiopulmonary arrest
por: Dirican, Adem, et al.
Publicado: (2014)

Are EMS bypass policies effective implementation strategies for intravenous alteplase for stroke?
por: Harris, Alex H. S., et al.
Publicado: (2020)

Effectiveness of alteplase in the very elderly after acute ischemic stroke
por: Yayan, Josef
Publicado: (2013)

Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
por: Nguyen, Chi Phuong, et al.
Publicado: (2023)

The budget impact of alteplase in the treatment of acute ischemic stroke in Egypt
por: Aref, Hany, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6thlq1isjengf6dupi9pq78pg8